Cargando…

Pro-Resolving Lipid Mediators in the Pathophysiology of Asthma

Asthma is one of the most important medical and social problems of our time due to the prevalence and the complexity of its treatment. Chronic inflammation that is characteristic of asthma is accompanied by bronchial obstruction, which involves various lipid mediators produced from n-6 and n-3 polyu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kytikova, Oxana, Novgorodtseva, Tatyana, Denisenko, Yulia, Antonyuk, Marina, Gvozdenko, Tatyana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631965/ https://www.ncbi.nlm.nih.gov/pubmed/31216723 http://dx.doi.org/10.3390/medicina55060284

Ejemplares similares

Molecular Targets of Fatty Acid Ethanolamides in Asthma
por: Kytikova, Oxana, et al.
Publicado: (2019)

Lipid-Induced Mechanisms of Metabolic Syndrome
por: Denisenko, Yulia K., et al.
Publicado: (2020)

Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma
por: Kytikova, Oxana Yu., et al.
Publicado: (2020)

Thermosensory Transient Receptor Potential Ion Channels and Asthma
por: Kytikova, Oxana Yu., et al.
Publicado: (2021)

1-O-alkyl-glycerols from Squid Berryteuthis magister Reduce Inflammation and Modify Fatty Acid and Plasmalogen Metabolism in Asthma Associated with Obesity
por: Denisenko, Yulia, et al.
Publicado: (2023)

Modification of the fatty acid composition of the erythrocyte membrane in patients with chronic respiratory diseases
por: Novgorodtseva, Tatyana P, et al.
Publicado: (2013)

The Mechanisms of the Regulation of Immune Response in Patients with Comorbidity of Chronic Obstructive Pulmonary Disease and Asthma
por: Kalinina, Elena P., et al.
Publicado: (2016)

Modification of fatty acids composition in erythrocytes lipids in arterial hypertension associated with dyslipidemia
por: Novgorodtseva, Tatyana P, et al.
Publicado: (2011)

Composition of fatty acids in plasma and erythrocytes and eicosanoids level in patients with metabolic syndrome
por: Novgorodtseva, Tatyana P, et al.
Publicado: (2011)

Effect of the prolonged high-fat diet on the fatty acid metabolism in rat blood and liver
por: Zhukova, Natalia V, et al.
Publicado: (2014)

Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis
por: Philippe, Réginald, et al.
Publicado: (2018)

Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

The Role of Toll-Like Receptors 2 and 4 in the Pathogenesis of Chronic Obstructive Pulmonary Disease
por: Sidletskaya, Karolina, et al.
Publicado: (2020)

Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?
por: Chávez-Castillo, Mervin, et al.
Publicado: (2021)

Specialized pro-resolving lipid mediators in endodontics: a narrative review
por: Aubeux, Davy, et al.
Publicado: (2021)

Specialized Pro-Resolving Lipid Mediators in Neonatal Cardiovascular Physiology and Diseases
por: Gila-Diaz, Andrea, et al.
Publicado: (2021)

The Role of Specialized Pro-Resolving Lipid Mediators in Inflammation-Induced Carcinogenesis
por: Torres, Wheeler, et al.
Publicado: (2023)

Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function
por: Brennan, Eoin, et al.
Publicado: (2021)

Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling
por: Díaz del Campo, Lucía Serrano, et al.
Publicado: (2022)

Specialized Pro-Resolving Lipid Mediators: Endogenous Roles and Pharmacological Activities in Infections
por: Rasquel-Oliveira, Fernanda S., et al.
Publicado: (2023)

Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid
por: Beyer, María Paz, et al.
Publicado: (2023)

New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease
por: Pascoal, Lívia Bitencourt, et al.
Publicado: (2022)

Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development
por: Yang, Ailin, et al.
Publicado: (2021)

Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators
por: Perez-Hernandez, Javier, et al.
Publicado: (2021)

Specialized Pro-resolving Lipid Mediators and Resolution of Viral Diseases
por: Ferri, Giulia, et al.
Publicado: (2023)

Pro-inflammatory and pro-resolving lipid mediators of inflammation in HIV: effect of aspirin intervention
por: Dalli, Jesmond, et al.
Publicado: (2023)

The Role of Pro-Resolving Lipid Mediators in Colorectal Cancer-Associated Inflammation: Implications for Therapeutic Strategies
por: Ungaro, Federica, et al.
Publicado: (2020)

Specialized Pro-Resolving Mediators and the Lymphatic System
por: Kraft, Jamie D., et al.
Publicado: (2021)

Ratio of Pro-Resolving and Pro-Inflammatory Lipid Mediator Precursors as Potential Markers for Aggressive Periodontitis
por: Zein Elabdeen, Hager R., et al.
Publicado: (2013)

Therapeutic Effects of Specialized Pro-Resolving Lipids Mediators on Cardiac Fibrosis via NRF2 Activation
por: Kang, Gyeoung Jin, et al.
Publicado: (2020)

Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury
por: Yin, Ping, et al.
Publicado: (2018)

Fatty Acid Oxidation and Pro-Resolving Lipid Mediators Are Related to Male Infertility
por: Signorini, Cinzia, et al.
Publicado: (2022)

Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders
por: Anderson, Per, et al.
Publicado: (2008)

Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response
por: Regidor, Pedro-Antonio, et al.
Publicado: (2020)

Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators
por: Yasmeen, Nusrath, et al.
Publicado: (2023)

Role of Specialized Pro-Resolving Mediators in Neuropathic Pain
por: Leuti, Alessandro, et al.
Publicado: (2021)

Reversal of Epithelial–Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids
por: Lee, Chang Hoon
Publicado: (2019)

Lipids in Liver Failure Syndromes: A Focus on Eicosanoids, Specialized Pro-Resolving Lipid Mediators and Lysophospholipids
por: Artru, Florent, et al.
Publicado: (2022)

The Inflammatory Role of Pro-Resolving Mediators in Endometriosis: An Integrative Review
por: de Fáveri, Cássia, et al.
Publicado: (2021)

The Use of Specialized Pro-Resolving Mediators in Biomaterial-Based Immunomodulation
por: Sousa, Ana Beatriz, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n5n82if4h8r4idli9iea74fg1j